NEW YORK, April 15, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Veterinary Vaccines Industry
http://www.reportlinker.com/p02070079/Global-Veterinary-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 100 companies including many key and niche players such as -
Bayer HealthCare AG
Biogenesis-Bago
Boehringer Ingelheim GmbH
Ceva Santé Animale
Heska Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
A. Companion Animal Vaccines I-3
B. Livestock Vaccines I-4
Porcine Vaccines I-4
Bovine Vaccines I-4
Poultry Vaccines I-4
Ovine Vaccines I-4
Equine Vaccines I-4
Other Animal Vaccines I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW & OUTLOOK II-1
Emergence of Newer Animal Diseases Drives the Global
Veterinary Vaccines Market II-1
Table 1: Global Animal Health Products Market by Product
Group (2013): Percentage Share Breakdown by Value sales for
Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed
Additives and Other Pharmaceuticals (includes corresponding
Graph/Chart) II-2
Table 2: Global Animal Health Products Market by Region
(2013): Percentage Share Breakdown by Value Sales for North
America, Europe, Latin America and Rest of World (includes
corresponding Graph/Chart) II-2
Market Outlook II-2
Scientific R&D - Crucial for Market Growth II-3
Mature Markets Vis-a-vis Emerging Markets II-4
Market Challenges II-4
A Highly Consolidated Market II-4
2. MARKET TRENDS & ISSUES II-5
Recombinant DNA Technology to Take Over the Industry II-5
Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems II-6
Global Efforts to Conquer FMD by an Effective Vaccine II-6
Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in
the Pipeline II-7
Pet Vaccines Trailing on a High Growth Track in Developing
Countries II-8
Over-Vaccination Trend May Prove Harmful II-9
Egg-Derived Veterinary Vaccines in Human Vaccine Facilities II-9
More Vaccines Needed to Prevent Zoonotic Infections II-9
Developments in the Poultry Vaccine Market II-10
Parasitic Vaccines Segment Holds Potential II-10
Pricing Affects the Livestock Vaccine Market II-11
OTC Market: A Potential Threat for Veterinarians II-11
Vaccination - Critical for Controlling Avian Influenza Virus II-11
3. PRODUCT OVERVIEW II-12
Vaccines - An Evolutionary Scan II-12
Veterinary Medicines - A Brief Review II-12
Concept Development II-13
Production of Vaccines II-13
Veterinary Vaccines - An Essential Component of Animal Healthcare II-14
What Does A Veterinary Vaccine Do? II-14
Classification of Veterinary Vaccines II-14
Companion Animal Vaccines II-14
Canine Vaccines II-15
Canine Distemper II-15
Canine Parvovirus II-16
Tracheobronchitis II-16
Canine Coronavirus II-16
Canine Leptospirosis II-16
Canine Giardia II-16
Canine Lyme borreliosis II-16
Canine Rabies II-16
Feline Vaccines II-17
Feline Panleukopenia Virus Vaccine II-17
Feline Calicivirus & Herpesvirus Vaccine II-17
Rabies Virus Vaccine II-17
Feline Leukemia Virus Vaccine II-17
Chlamydia, Feline Infectious Peritonitis, and Ringworm
Vaccines II-18
Livestock Vaccines II-18
Bovine Vaccines II-18
Bovine virus diarrhoea - Mucosal disease (BVD-MD) II-18
Johne's disease II-18
Infectious Bovine Rhinotracheitis (IBR) II-18
Blackleg II-18
Neosporosis II-18
Poultry Vaccines II-19
Ovine Vaccines II-19
Porcine Vaccines II-19
Equine Vaccines II-19
Aquaculture Vaccines II-20
A Tabular Analysis on Select Animal Diseases Controlled by
Vaccines II-20
Vaccination and Its Reactions II-20
Veterinary Vaccines- Latest Breakthroughs II-20
Marker/DIVA Vaccines II-21
DNA Vaccines II-21
Gene-Deleted Vaccines II-21
Viral-Vectored Vaccines II-21
4. NOTES ON SELECT ANIMAL DISEASES II-22
Brucellosis II-22
Tuberculosis II-22
Johne's disease II-22 Spirochete Associated Diseases II-22
Respiratory Disease in Goats, Sheep, and Cattle II-22
Porcine Respiratory Diseases II-23
Mastitis II-23
African swine fever II-23
Avian Influenza II-23
East Coast Fever II-23
Hemorrhagic Septicemia II-24
Foot-And-Mouth Disease II-24
Japanese Encephalitis II-24
Rift Valley Fever II-24
Equine Virus Infection II-24
5. PRODUCT LAUNCHES AND INNOVATIONS II-25
Ceva Animal Health Vietnam Unveils Hyogen® II-25
Merck Introduces SE Guard™ Vaccine against Salmonella Enteritidis II-25
Hygieia Biological Unveils New Vaccine for Streptococcus Mastitis II-25
MSD Animal Health Announces Bovilis IBR Marker Inac II-25
BIVI Launches New VETERA® XP Vaccine Range II-26
BIVI Launches FLEXcombo® Vaccine II-26
Merck Animal Health Launches Circumvent PCV G2 Vaccine II-26
MSD Animal Health Introduces New Equilis Prequenza Vaccine II-27
Zoetis Launches Bovi-Shield Gold One Shot™ Respiratory Vaccine II-27
MSD Animal Health Introduces Nobivac L4 Vaccine II-27
Merck Animal Health Unveils Vetsulin® II-27
Bayer Unveils Serersto™ Flea- and Tick- Collar for Cats and Dogs II-28
MSD Animal Health Introduces INNOVAX®-ND-SB in India II-28
Zoetis Launches Fostera PCV MH Combination Vaccine II-28
Boehringer Ingelheim Vetmedica Launches Vaccine for ERAV II-29
Merck Animal Health Launches Bron-Newcavac-SETM II-29
Pfizer Animal Health Introduces Poulvac E Coli II-29
Ceva Sante Animale Launches Vectormune® AI II-29
Newport Laboratories Introduces ParaSail® II-30
Novartis Animal Health Launches BRD Shield II-30
Ceva Animal Health Launches CEVAC® CORYMUNE 7K and CEVAC®
CORYMUNE 4K II-30
Pfizer Introduces Equivac® HeV Vaccine II-30
BIVI Unveils New Generation Canine Vaccine Line II-31
Merial Animal Health Introduces New Pack Size of Circovac Vaccine II-31
MSD Animal Health Unveils New Vaccine for Goats and Sheep II-31
Virbac Launches First Vaccine in EU for Canine Leishmaniosis II-32
Yissum Research and Development Announces Production of
Vaccine to Offer Protection against CME II-32
Virbac Introduces Bovidec II-32
Intervet/Schering-Plough Animal Health Introduces a New Web
Site for Innovax recombinant Vaccines Product Line II-32
Pfizer Animal Health Introduces the First E. Coli Bacterial
Extract Vaccine II-33
Intervet/Schering-Plough Unveils BacuCheck™ ELISA Test II-33
Merck Unveils Coccivac®-D2 Poultry Vaccine II-33
Merck Animal Health Introduces NOBIVAC® Myxo-RHD Vaccine II-33
Pfizer Animal Health Canada Introduces Fostera™ PCV Vaccine II-33
Brentec Vaccines Introduces Poultry Vaccine II-34
Intervet/Schering-Plough Animal Health Launches Atrophic
Rhinitis Vaccine for Pigs II-34
Merial Introduces VAXXITEK HVT + IBD Vaccine II-34
Agrilabs Introduces MpB Cattle Vaccine II-34
Ceva Launches New VECTORMUNE HVT-NDV® Poultry Vaccine II-34
6. RECENT INDUSTRY ACTIVITY II-35
Elanco Inks Agreement to Take Over Assets of Lohmann SE and
Lohmann Animal Health II-35
Biogénesis Bagó to Construct FMD Vaccine Facility in China II-35
Boehringer Ingelheim Teams Up with Taizhou China Medical City
to Construct Veterinary Vaccines Production Plant II-36
Heska Acquires 54.6% Majority Stake in Cuattro Veterinary USA II-36
Harrisvaccines Expands Its License Agreement with Alphavax to
Include Companion Animal Vaccines II-36
AgriLabs Secures USDA Approval for Pulmo-Guard Vaccine for Cattle II-37
IDT Acquires Assets of Riemser Pharma II-37
MWI Veterinary Supply Acquires Assets of IVESCO Holdings II-37
Imaxio Enters into R&D partnership agreement with VitamFero II-38
Elanco Animal Health Signs Distribution Agreement for
Prevtec's Swine Vaccine II-38
Valneva and Boehringer Ingelheim Ink Research License Agreement II-38
Imaxio Inks Agreement with Leading Animal Health Laboratory II-38
Heska Divests Assets to Elanco Animal Health II-38
Bayer Expands its Centre for Innovation and Development II-39
Bayer HealthCare Receives FDA Approval to Market ProstaMate™
and OvaCyst™ II-39
MSD Presents Data Regarding Porcilis® Porcine Reproductive and
Respiratory Syndrome (PRRS) Vaccine II-39
Merck Animal Health's Vista® MLV Vaccine Line Gets USDA Approval II-40
Harrisvaccines Expands License Agreement with AlphaVax II-40
Virbac Gets Limited Marketing Authorization for Gudair® II-41
Merial Receives Exceptional Approval for Schmallenberg Vaccine
in France II-41
Zoetis China JV Receives Approval for Swine Vaccine II-41
Vetanco Secures Approval from SENASA for BiotechVac Vaccine II-41
Intercell Merges with Vivalis II-42
Tianjin Ringpu Bio-technology Secures Approval from Ministry
of Agriculture for Porcine Circovirus Type 2 Vaccine II-42
Merial Korea Chusik Hoesa and Special Vaccine Ink Contract II-42
Elanco Animal Health to Take Over Master Guard and Titanium
Vaccine Brands of AgriLabs II-42
Pfizer Animal Health Renames Escherichia coli Mastitis Vaccine
to ENVIRACOR J-5 II-42
Global Green Awaits USDA Approval for Salmogenics Vaccine II-43
Pfizer to Restructure Indian Animal Health Unit II-43
Lohmann Animal Health Establishes Lohmann Animal Health Mexico II-43
DSM and Merial Sign Collaboration Agreement for Producing
Algae Based Vaccines II-43
Heska Enters into Distribution Partnership with MWI Veterinary
Supply II-44
Bayer HealthCare Inks Agreement to Acquire KMG Chemicals'
Animal Health Business II-44
Pfizer's Equivac HeV Vaccine for Equines Granted APVMA Approval II-44
Boehringer Ingelheim to Expand Porcine Vaccines' Production
Capacity II-44
BIVI Launches Bronchi-Shield ORAL II-45
Sanofi Inks Agreement to Take Over Animal Health Division of
Dosch Pharmaceuticals II-45
Hester Biosciences and Innoves Animal Health Ink Business
Transfer Agreement II-45
Benchmark Holdings Acquires Braintree Vaccine Manufacturing
Plant of Novartis Animal Health II-45
Merial Takes Over Newport Laboratories II-46
Delphi Announces Successful Application of Staby [R]
Technology to DNA Vaccine In-Vivo Testing II-46
FATRO and VIVALIS Ink Agreement II-46
Kitasato Daiichi Sankyo Vaccine to Discontinue Animal Vaccine
Business II-46
Merial Unveils PUREVAX® Recombinant FeLV II-46
Merck Animal Health Develops Vaccine for Schmallenberg Virus II-47
Antelope Valley Bios Secures Conditional License from United
States Department of Agriculture II-47
Pfizer Animal Health Expands its R&D Global Headquarters II-47
Merck Renames Intervet/Schering-Plough Animal Health as Merck
Animal Health II-47
Sanofi and Merck to Operate Separate Animal Health Businesses II-48
Centegen Inks Licensing Agreement with Merial for CEN-102
Staphylococcal Vaccine II-48
Pfizer Poultry Health Acquires Alpharma II-48
Virbac and Schweitzer Biotech to form Joint Venture SBC-Virbac II-49
Pfizer Animal Health Enters into Agreement with Jilin Guoyuan
Animal Health II-49
Cadila Healthcare Acquires Bremer Pharma II-49
IVRI Inks MoU with University of Glasgow and Moredun Research
Institute II-49
Vivalis and Kyoto Biken Laboratories Enter into Commercial
Licensing Agreement II-50
Xinjiang Tecon Animal Husbandry Biotechnology and Taiwan
Maoxing Biotechnology Ink Licensing Agreement II-50
The Ugandan Government Enters into Partnership with Brentec
Vaccines International II-50
Malaysian Government to Collaborate with Maryland University II-50
Bioniche Life Sciences Sets up Vaccine Manufacturing Unit II-51
Bayer Obtains European Commission's Approval for Veraflox® and
Procox® II-51
MSD Expands Elkhorn Biotechnology Excellence Center's
Vaccination Unit II-52
Hester Biosciences and Him Electronics Enter into Collaboration II-52
Boehringer Ingelheim Secures Approval in Europe II-52
Tangshan Yian Biological Engineering Secures Production
License from Ministry of Agriculture for RabEnd II-52
Merck Animal Health Secures Regulatory Approval to
Commercialize AQUAVAC® Strep Sa Vaccine in Brazil II-52
7. FOCUS ON SELECT GLOBAL PLAYERS II-53
Bayer HealthCare AG (Germany) II-53
Biogenesis-Bago (Argentina) II-53
Boehringer Ingelheim GmbH (Germany) II-53
Ceva Santé Animale (France) II-54
Heska Corporation (US) II-54
Indian Immunologicals Ltd (India) II-54
Lohmann Animal Health (US) II-55
Merck Animal Health (US) II-55
Merial Ltd. (US) II-56
Protein Sciences Corporation (US) II-56
Virbac SA (France) II-56
Zoetis Inc. (US) II-57
8. GLOBAL MARKET PERSPECTIVE II-58
Table 3: World Recent Past, Current & Future Analysis for
Veterinary Vaccines by Geographic Region - US, Europe and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-58
Table 4: World Historic Review Veterinary Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-59
Table 5: World 15-Year Perspective for Veterinary Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-60
Table 6: World Recent Past, Current & Future Analysis for
Companion Animal Vaccines by Geographic Region - US, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) II-61
Table 7: World Historic Review for Companion Animal Vaccines
by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-62
Table 8: World 15-Year Perspective for Companion Animal
Vaccines by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Europe and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-63
Table 9: World Recent Past, Current & Future Analysis for
Companion Animal Vaccines by Product Segment - Canine Vaccines
and Feline Vaccines Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) II-64
Table 10: World Historic Review for Companion Animal Vaccines
by Product Segment - Canine Vaccines and Feline Vaccines
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-65
Table 11: World 15-Year Perspective for Companion Animal
Vaccines by Product Segment - Percentage Breakdown of Dollar
Sales for Canine Vaccines & Feline Vaccines Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) II-66
Table 12: World Recent Past, Current & Future Analysis for
Canine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-67
Table 13: World Historic Review for Canine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-68
Table 14: World 15-Year Perspective for Canine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-69
Table 15: World Recent Past, Current & Future Analysis for
Feline Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-70
Table 16: World Historic Review for Feline Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-71
Table 17: World 15-Year Perspective for Feline Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-72
Table 18: World Recent Past, Current & Future Analysis for
Livestock Vaccines by Geographic Region - US, Europe and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-73
Table 19: World Historic Review for Livestock Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-74
Table 20: World 15-Year Perspective for Livestock Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-75
Table 21: World Recent Past, Current & Future Analysis for
Livestock Vaccines by Product Segment - Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2013 through 2020 (includes corresponding Graph/Chart) II-76
Table 22: World Historic Review for Livestock Vaccines by
Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal
Vaccines Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-77
Table 23: World 15-Year Perspective for Livestock Vaccines by
Product Segment - Percentage Breakdown of Dollar Sales for
Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines Markets
for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-78
Table 24: World Recent Past, Current & Future Analysis for
Porcine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-79
Table 25: World Historic Review for Porcine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-80
Table 26: World 15-Year Perspective for Porcine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-81
Table 27: World Recent Past, Current & Future Analysis for
Bovine Vaccines by Geographic Region - US, Europe & Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-82
Table 28: World Historic Review for Bovine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-83
Table 29: World 15-Year Perspective for Bovine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-84
Table 30: World Recent Past, Current & Future Analysis for
Poultry Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-85
Table 31: World Historic Review for Poultry Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-86
Table 32: World 15-Year Perspective for Poultry Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-87
Table 33: World Recent Past, Current & Future Analysis for
Ovine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-88
Table 34: World Historic Review for Ovine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-89
Table 35: World 15-Year Perspective for Ovine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-90
Table 36: World Recent Past, Current & Future Analysis for
Equine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-91
Table 37: World Historic Review for Equine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-92
Table 38: World 15-Year Perspective for Equine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-93
Table 39: World Recent Past, Current & Future Analysis for
Other Animal Vaccines by Geographic Region - US, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-94
Table 40: World Historic Review for Other Animal Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-95
Table 41: World 15-Year Perspective for Other Animal Vaccines
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Europe and Rest of World Markets for Years 2006, 2014&
2020 (includes corresponding Graph/Chart) II-96
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Food Safety Concerns and Biotechnological Offerings Drive
the Vaccine Market III-1
Dogs and Cats Obesity Vaccines Receive First US Patent III-1
H5N1 Virus: A Conundrum for the US Industry III-2
Product launches III-2
Strategic Corporate Developments III-8
Select Major Players III-16
B.Market Analytics III-19
Table 42: The US Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/ Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-19
Table 43: The US Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-20
Table 44: The US 15-Year Perspective for Veterinary Vaccines
by Product Group/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-21
2. EUROPE III-22
A.Market Analysis III-22
Steady Market Growth Expected Due to Superior Livestock
Management III-22
Regulations III-22
EU Animal Welfare Strategy III-23
Product Launches and Innovations III-23
Strategic Corporate Developments III-24
Select Major Players III-28
B.Market Analytics III-30
Table 45: European Recent Past, Current & Future Analysis
for Veterinary Vaccines by Geographic Region - France,
Germany, Italy, UK, Spain, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-30
Table 46: European Historic Review for Veterinary Vaccines
by Geographic Region - France, Germany, Italy, UK, Spain,
and Rest of Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-31
Table 47: European 15-Year Perspective for Veterinary
Vaccines by Geographic Region - Percentage Breakdown of
Dollar Sales for France, Germany, Italy, UK, Spain, and Rest
of Europe Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-32
Table 48: European Recent Past, Current & Future for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-33
Table 49: European Historic Review for Veterinary Vaccines
by Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-34
Table 50: European 15-Year Perspective for Veterinary
Vaccines by Product Group/ Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-35
2a. FRANCE III-36
A.Market Analysis III-36
Product Launches and Innovations III-36
Strategic Corporate Developments III-37
Select Major Players III-38
B.Market Analytics III-40
Table 51: French Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines and Equine Vaccines)
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-40
Table 52: French Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines and Equine Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-41
Table 53: French 15-Year Perspective for Veterinary Vaccines
by Product Group/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-42
2b. GERMANY III-43
A.Market Analysis III-43
Strategic Corporate Developments III-43
Select Major Players III-45
B.Market Analytics III-46
Table 54: German Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines and Equine Vaccines)
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-46
Table 55: German Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines and Equine Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-47
Table 56: German 15-Year Perspective for Veterinary Vaccines
by Product Group/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-48
2c. ITALY III-49
A.Market Analysis III-49
Strategic Corporate Development III-49
B.Market Analytics III-50
Table 57: Italian Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-50
Table 58: Italian Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-51
Table 59: Italian 15-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-52
2d. SPAIN III-53
Market Analysis III-53
Table 60: Spanish Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-54
Table 61: Spanish Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-55
Table 62: Spanish 15-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-56
2e. THE UNITED KINGDOM III-57
A.Market Analysis III-57
Product Launches and Innovations III-57
Strategic Corporate Developments III-58
B.Market Analytics III-60
Table 63: The UK Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-60
Table 64: The UK Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-61
Table 65: The UK 15-Year Perspective for Veterinary Vaccines
by Product Group/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-62
2f. REST OF EUROPE III-63
A.Market Analysis III-63
A Review of Select Regional Markets III-63
The Netherlands III-63
Denmark III-63
Russia Mass-Produces Vaccines against Avian Flu III-64
B.Market Analytics III-65
Table 66: Rest of Europe Recent Past, Current & Future
Analysis for Veterinary Vaccines by Product Group/Segment -
Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-65
Table 67: Rest of Europe Historic Review for Veterinary
Vaccines by Product Group/Segment - Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock
Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal
Vaccines) Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-66
Table 68: Rest of Europe 15-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-67
3. ASIA-PACIFIC III-68
A.Market Analysis III-68
Product Launches and Innovations III-68
Strategic Corporate Developments III-70
Select Key Player III-74
Indian Immunologicals Ltd. (India) III-74
B.Market Analytics III-75
Table 69: Asia-Pacific Recent Past, Current & Future
Analysis for Veterinary Vaccines by Region - China and Rest
of Asia-Pacific Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-75
Table 70: Asia-Pacific Historic Review for Veterinary
Vaccines by Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-76
Table 71: Asia-Pacific 15-year Perspective for Veterinary
Vaccines by Region - Percentage Breakdown of Dollar Sales
for China and Rest of Asia-Pacific Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-77
3a. CHINA III-78
A.Market Analysis III-78
Increased Livestock Output and Emerging Pet Industry Lead to
Higher Vaccine Demand III-78
Growing Pet Industry Holds Promise III-79
Threat of Avian Influenza Outbreaks Creates Market for
Effective Vaccine III-79
Demand for Higher-Quality Swine Fever Vaccine III-79
Demand for Effective PRRS Vaccines by Foreign Manufacturers III-79
FMD Epidemics Cause Increased demand for Vaccine III-80
Effective Rabies Vaccine Needed to Curb Dog Menace III-80
Highly Consolidated Chinese Veterinary Market III-80
Product Launch III-81
Strategic Corporate Developments III-81
B.Market Analytics III-83
Table 72: Chinese Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Segment - Porcine Vaccines,
Poultry Vaccines, and Other Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-83
Table 73: Chinese Historic Review for Veterinary Vaccines by
Product Segment - Porcine Vaccines, Poultry Vaccines, and
Other Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-84
Table 74: Chinese 15-Year Perspective for Veterinary
Vaccines by Product Segment - Percentage Breakdown of Dollar
Sales for Porcine Vaccines, Poultry Vaccines, and Other
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-85
3b. REST OF ASIA-PACIFIC III-86
A.Market Analysis III-86
Focus on Select Regions III-86
India III-86
Major Players III-86
Indigenous Bird Flu Vaccine by ICAR III-87
North Korea III-87
Taiwan III-87
Taiwan's Animal Healthcare Industry under Scan III-87
Australia III-87
A Note on Australian Veterinary Therapeutics Market III-87
Vietnam III-88
Vietnam Imports Bird Flu Vaccines III-88
Product Launches and Innovations III-88
Strategic Corporate Developments III-90
Select Key Player III-92
B.Market Analytics III-93
Table 75: Rest of Asia-Pacific Recent Past, Current & Future
Market Analysis for Veterinary Vaccines in US$ Thousand for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-93
Table 76: Rest of Asia-Pacific Historic Review for
Veterinary Vaccines in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-94
4. LATIN AMERICA III-95
A.Market Analysis III-95
Strategic Corporate Developments III-95
Biogenesis-Bagó - A Key Argentinian Player III-96
B.Market Analytics III-97
Table 77: Latin American Recent Past, Current & Future
Analysis for Veterinary Vaccines by Region - Brazil and Rest
of Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-97
Table 78: Latin American Historic Review for Veterinary
Vaccines by Region - Brazil and Rest of Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-98
Table 79: Latin American 15-year Perspective for Veterinary
Vaccines by Region - Percentage Breakdown of Dollar Sales
for Brazil and Rest of Latin America Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-99
5. REST OF WORLD III-100
A.Market Analysis III-100
Focus on Select Regions III-100
Canada III-100
Overview of the Canadian Animal Health Industry III-100
Imports and Manufacture of Veterinary Biologics III-100
First to Access E. coli 0157:H7 Vaccine III-100
Product Launches and Innovations III-101
Strategic Corporate Development III-101
B.Market Analytics III-102
Table 80: Rest of World Recent Past, Current & Future
Analysis for Veterinary Vaccines by Product Group/Segment -
Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-102
Table 81: Rest of World Historic Review for Veterinary
Vaccines by Product Group/Segment - Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock
Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal
Vaccines) Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-103
Table 82: Rest of World 15-Year Perspective for Veterinary
Vaccines by Product Group/ Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-104
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 100 (including Divisions/Subsidiaries - 123)
The United States (24)
Canada (2)
Japan (6)
Europe (36)
- France (4)
- Germany (8)
- The United Kingdom (5)
- Italy (3)
- Spain (4)
- Rest of Europe (12)
Asia-Pacific (Excluding Japan) (28)
Latin America (19)
Africa (5)
Middle East (3)
To order this report: Global Veterinary Vaccines Industry
http://www.reportlinker.com/p02070079/Global-Veterinary-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article